Web Stats Provided By Google Analytics

Friday, January 5, 2018

Zacks: Analysts Anticipate CymaBay Therapeutics Inc (CBAY) Will...

... Wace North America L.P. bought a new position in shares of CymaBay Therapeutics in the 2nd quarter worth $242,000. Ardsley Advisory Partners lifted its holdings in shares of CymaBay Therapeutics by 66.2% in the 2nd quarter. Ardsley Advisory Partners ...
http://ift.tt/2qvUtYs

No comments:

Post a Comment

Popular Ardsley Roundup Posts